Ginkgo Bioworks Hldgs Inc (DNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2003 | 03-2003 | 12-2002 | 09-2002 | 06-2002 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 260,476 | 148,701 | 208,130 | 356,530 | 119,619 |
| Marketable Securities | 955,337 | 936,730 | 826,442 | 767,615 | 849,457 |
| Receivables | 679,456 | 390,135 | 418,481 | 302,091 | 327,505 |
| Inventories | 422,414 | 411,107 | 393,542 | 394,593 | 380,197 |
| Income taxes - deferred | N/A | N/A | 82,299 | N/A | N/A |
| Other current assets | 0 | 0 | 103,148 | 0 | 0 |
| TOTAL | $2,552,280 | $2,123,962 | $2,082,784 | $2,029,385 | $1,873,567 |
| Non-Current Assets | |||||
| PPE Net | 1,146,875 | 1,114,618 | 1,068,734 | 1,017,121 | 969,277 |
| Investments And Advances | 785,877 | 567,668 | 567,286 | 1,049,799 | 1,085,251 |
| Intangibles | 2,199,938 | 2,220,944 | 2,242,557 | 2,299,465 | 2,339,024 |
| Other Non-Current Assets | 793,345 | 800,895 | 796,758 | 277,654 | 326,615 |
| TOTAL | $4,926,035 | $4,704,125 | $4,675,335 | $4,644,039 | $4,720,167 |
| Total Assets | $7,478,315 | $6,828,087 | $6,758,119 | $6,673,424 | $6,593,734 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 69,215 | 58,525 | 51,380 | 52,318 | 54,824 |
| TOTAL | $598,721 | $643,993 | $646,660 | $588,216 | $522,614 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | 20,044 | N/A | N/A |
| Other Non-Current Liabilities | 580,040 | 790,131 | 554,728 | 537,451 | 520,719 |
| TOTAL | $1,026,661 | $790,131 | $772,575 | $784,430 | $776,207 |
| Total Liabilities | $1,625,382 | $1,434,124 | $1,419,235 | $1,372,646 | $1,298,821 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,035,698 | 1,020,304 | 1,025,156 | 1,029,387 | 1,035,713 |
| Common Shares | 10,357 | 10,209 | 10,256 | 10,294 | 10,357 |
| Retained earnings | -1,431,120 | -1,510,392 | -1,590,366 | -1,631,873 | -1,652,231 |
| Other shareholders' equity | 283,621 | 261,202 | 268,642 | 259,707 | 242,947 |
| TOTAL | $5,852,933 | $5,393,963 | $5,338,884 | $5,300,778 | $5,294,913 |
| Total Liabilities And Equity | $7,478,315 | $6,828,087 | $6,758,119 | $6,673,424 | $6,593,734 |